Alessandra Bisagni

8PUBLICATIONS
52CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 13, 2025
Metastatic Carcinomas at the Episiotomy Site: A Systematic Literature Review.

Andrea Palicelli, Gabriele Tonni, Federica Torricelli

|Oct 19, 2023
Spatial Distribution of Immune Cells Drives Resistance to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

Benedetta Donati, Francesca Reggiani, Federica Torricelli

|Jul 07, 2023
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.

Federica Miglietta, Moira Ragazzi, Bethania Fernandes

|Nov 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1.

Andrea Palicelli, Stefania Croci, Alessandra Bisagni

|Apr 25, 2018
Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients.

Alessandra Bisagni, Maria Pagano, Sally Maramotti

|May 27, 2017
Primary histiocytic sarcoma presenting as diffuse leptomeningeal disease: Case description and review of the literature.

Magda Zanelli, Moira Ragazzi, Giovanni Marchetti

Pageof 2

Frequent Collaborators

3 joint publications

Giacomo Santandrea

2 joint publications

Giancarlo Bisagni

2 joint publications

Andrea Palicelli

2 joint publications

Eleonora Zanetti